{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:45:52Z","timestamp":1763729152028,"version":"3.45.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-025-11139-0","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:17:07Z","timestamp":1740529027000},"page":"6311-6324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational framework for minimizing off-target toxicity in capecitabine treatment using natural compounds"],"prefix":"10.1007","volume":"29","author":[{"given":"Tanya","family":"Jamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamta","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinni","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramakrishnan","family":"Parthasarathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"11139_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-4651-7","volume":"20","author":"H Khalil","year":"2020","unstructured":"Khalil H, Huang C (2020) Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res 20:1\u201313","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"11139_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrd.2016.184","volume":"15","author":"RK Harrison","year":"2016","unstructured":"Harrison RK (2016) Phase II and phase III failures: 2013\u20132015. Nat Rev Drug Discov 15(12):817\u2013818","journal-title":"Nat Rev Drug Discov"},{"issue":"509","key":"11139_CR3","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.1126\/scitranslmed.aaw8412","volume":"11","author":"A Lin","year":"2019","unstructured":"Lin A, Giuliano CJ, Palladino A, John KM, Abramowicz C, Yuan ML et al (2019) Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci Trans Med 11(509):8412","journal-title":"Sci Trans Med"},{"issue":"8","key":"11139_CR4","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.drudis.2016.04.021","volume":"21","author":"S Whitebread","year":"2016","unstructured":"Whitebread S, Dumotier B, Armstrong D, Fekete A, Chen S, Hartmann A et al (2016) Secondary pharmacology: screening and interpretation of off-target activities\u2013focus on translation. Drug Disc Today 21(8):1232\u20131242","journal-title":"Drug Disc Today"},{"issue":"6","key":"11139_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/CBM-2009-0111","volume":"5","author":"IV Krishna","year":"2009","unstructured":"Krishna IV, Vanaja G, Kumar N, Suman G (2009) Cytotoxic studies of anti-neoplastic drugs on human lymphocytes\u2013In vitro studies. Cancer Biomark 5(6):261\u2013272","journal-title":"Cancer Biomark"},{"key":"11139_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2165\/00002018-200831080-00007","volume":"31","author":"R Leone","year":"2008","unstructured":"Leone R, Sottosanti L, Iorio ML, Santuccio C, Conforti A, Sabatini V et al (2008) Drug-related deaths: an analysis of the Italian spontaneous reporting database. Drug Saf 31:703\u2013713","journal-title":"Drug Saf"},{"key":"11139_CR7","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S11250","author":"BR Hirsch","year":"2011","unstructured":"Hirsch BR, Zafar SY (2011) Capecitabine in the management of colorectal cancer. Cancer Manag Res. https:\/\/doi.org\/10.2147\/CMAR.S11250","journal-title":"Cancer Manag Res"},{"issue":"19","key":"11139_CR8","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1039\/D4RA01683A","volume":"14","author":"M Cybulski","year":"2024","unstructured":"Cybulski M, Zaremba-Czogalla M, Trzaskowski B, Kubiszewski M, Tobiasz J, Jaromin A et al (2024) The conjugates of 5\u2032-deoxy-5-fluorocytidine and hydroxycinnamic acids\u2013synthesis, anti-pancreatic cancer activity and molecular docking studies. RSC Adv 14(19):13129\u201313141","journal-title":"RSC Adv"},{"key":"11139_CR9","unstructured":"Dean L, Kane M (2020) Capecitabine therapy and DPYD genotype. Medical Genetics Summaries.\nhttp:\/\/www.ncbi.nlm.nih.gov\/books\/NBK385155\/"},{"key":"11139_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2017.05.001","volume":"62","author":"M Obadia","year":"2017","unstructured":"Obadia M, Leclercq D, Wasserman J, Galanaud D, Dormont D, Sahli-Amor M et al (2017) Capecitabine-induced acute toxic leukoencephalopathy. Neurotoxicology 62:1\u20135","journal-title":"Neurotoxicology"},{"issue":"11","key":"11139_CR11","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1212\/01.wnl.0000187313.83515.7e","volume":"65","author":"A Videnovic","year":"2005","unstructured":"Videnovic A, Semenov I, Chua-Adajar R, Baddi L, Blumenthal D, Beck A et al (2005) Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. Neurology 65(11):1792\u20131794","journal-title":"Neurology"},{"issue":"4","key":"11139_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000078335","volume":"66","author":"B Niemann","year":"2004","unstructured":"Niemann B, Rochlitz C, Herrmann R, Pless M (2004) Toxic encephalopathy induced by capecitabine. Oncology 66(4):331\u2013335","journal-title":"Oncology"},{"issue":"03","key":"11139_CR13","first-page":"258","volume":"9","author":"J Feige","year":"2023","unstructured":"Feige J, Klausner F, Pfaff JA, Trinka E, Pikija S, Safdarian M (2023) Stroke-like presentation of acute toxic leukoencephalopathy due to capecitabine treatment with extensive intramyelinic edema. Chronic Dis Trans Med 9(03):258\u2013262","journal-title":"Chronic Dis Trans Med"},{"issue":"1","key":"11139_CR14","first-page":"2408269","volume":"2016","author":"A Bougea","year":"2016","unstructured":"Bougea A, Voskou P, Kilidireas C, Andreadou E (2016) Capecitabine induced multifocal leukoencephalopathy: do we have always to switch off the chemotherapy? Case Rep Oncol Med 2016(1):2408269","journal-title":"Case Rep Oncol Med"},{"key":"11139_CR15","doi-asserted-by":"publisher","first-page":"122735","DOI":"10.1016\/j.ijpharm.2023.122735","volume":"635","author":"D Kumar","year":"2023","unstructured":"Kumar D, Gautam A, Kundu PP (2023) Synthesis of acrylamide-g-melanin\/itaconic acid-g-psyllium based nanocarrier for capecitabine delivery: In vivo and in vitro anticancer activity. Int J Pharm 635:122735","journal-title":"Int J Pharm"},{"issue":"2","key":"11139_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3(2):133\u2013149","journal-title":"Int J Nanomed"},{"key":"11139_CR17","doi-asserted-by":"crossref","unstructured":"Liang T, Lu L, Song X, Qi J, Wang J. 2022 Combination of microtubule targeting agents with other antineoplastics for cancer treatment. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 1877(5): 188777","DOI":"10.1016\/j.bbcan.2022.188777"},{"issue":"12","key":"11139_CR18","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1021\/acs.jmedchem.1c00100","volume":"64","author":"W Shuai","year":"2021","unstructured":"Shuai W, Wang G, Zhang Y, Bu F, Zhang S, Miller DD et al (2021) Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy. J Med Chem 64(12):7963\u20137990","journal-title":"J Med Chem"},{"key":"11139_CR19","doi-asserted-by":"crossref","unstructured":"Cragg GM, Newman DJ. 2013 Natural products: a continuing source of novel drug leads. Biochimica et Biophysica Acta (BBA)-General Subjects. 1830(6): 3670\u201395","DOI":"10.1016\/j.bbagen.2013.02.008"},{"issue":"22","key":"11139_CR20","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.3390\/ijms232214058","volume":"23","author":"L Layos","year":"2022","unstructured":"Layos L, Mart\u00ednez-Balibrea E, Ruiz de Porras V (2022) Curcumin: a novel way to improve quality of life for colorectal cancer patients? Int J Mol Sci 23(22):14058","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11139_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/metabo2020303","volume":"2","author":"DA Dias","year":"2012","unstructured":"Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2(2):303\u2013336","journal-title":"Metabolites"},{"key":"11139_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104222","volume":"130","author":"M Sinha","year":"2021","unstructured":"Sinha M, Gupta A, Gupta S, Singh P, Pandit S, Chauhan SS et al (2021) Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design. Comput Biol Med 130:104222","journal-title":"Comput Biol Med"},{"key":"11139_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173061","author":"S Brogi","year":"2019","unstructured":"Brogi S (2019) Computational approaches for drug discovery. Molecules. https:\/\/doi.org\/10.3390\/molecules24173061","journal-title":"Molecules"},{"key":"11139_CR24","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. 2018 DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic acids research. 46(D1): D1074-D82","DOI":"10.1093\/nar\/gkx1037"},{"key":"11139_CR25","unstructured":"Food U, Administration D. 2016 FDA issues advice to make earliest stages of clinical drug development more efficient. http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2006\/ucm108576.htm), Accessed on 04 July 2016"},{"key":"11139_CR26","unstructured":"Wepner B, Wagner P, Neuberger S, Fr\u00f6hlich P, Motnikar L, Kostic T. 2023 Healthier Lives through Food Insight Report."},{"issue":"S1","key":"11139_CR27","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"N Guex","year":"2009","unstructured":"Guex N, Peitsch MC, Schwede T (2009) Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30(S1):S162\u2013S173","journal-title":"Electrophoresis"},{"issue":"13","key":"11139_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"key":"11139_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bap024","author":"V Neveu","year":"2010","unstructured":"Neveu V, Perez-Jim\u00e9nez J, Vos F, Crespy V, du Chaffaut L, Mennen L et al (2010) Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database. https:\/\/doi.org\/10.1093\/database\/bap024","journal-title":"Database"},{"issue":"1","key":"11139_CR30","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","volume":"8","author":"K Mohanraj","year":"2018","unstructured":"Mohanraj K, Karthikeyan BS, Vivek-Ananth R, Chand RB, Aparna S, Mangalapandi P et al (2018) IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics. Sci Rep 8(1):4329","journal-title":"Sci Rep"},{"key":"11139_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bau055","author":"C-W Tung","year":"2014","unstructured":"Tung C-W, Lin Y-C, Chang H-S, Wang C-C, Chen I-S, Jheng J-L et al (2014) TIPdb-3D: the three-dimensional structure database of phytochemicals from Taiwan indigenous plants. Database. https:\/\/doi.org\/10.1093\/database\/bau055","journal-title":"Database"},{"issue":"1","key":"11139_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-020-00478-9","volume":"13","author":"M Sorokina","year":"2021","unstructured":"Sorokina M, Merseburger P, Rajan K, Yirik MA, Steinbeck C (2021) COCONUT online: collection of open natural products database. J Cheminform 13(1):2","journal-title":"J Cheminform"},{"key":"11139_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70780","volume":"11","author":"A Rutz","year":"2022","unstructured":"Rutz A, Sorokina M, Galgonek J, Mietchen D, Willighagen E, Gaudry A et al (2022) The LOTUS initiative for open knowledge management in natural products research. Elife 11:e70780","journal-title":"Elife"},{"issue":"D1","key":"11139_CR34","doi-asserted-by":"publisher","first-page":"D1217","DOI":"10.1093\/nar\/gkx1026","volume":"46","author":"X Zeng","year":"2018","unstructured":"Zeng X, Zhang P, He W, Qin C, Chen S, Tao L et al (2018) NPASS: natural product activity and species source database for natural product research, discovery and tool development. Nucleic Acids Res 46(D1):D1217\u2013D1222","journal-title":"Nucleic Acids Res"},{"key":"11139_CR35","unstructured":"Studio D (2008) Discovery studio. Accelrys. 21, San Diego."},{"issue":"1","key":"11139_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/70100051","volume":"7","author":"TI Oprea","year":"2002","unstructured":"Oprea TI (2002) Virtual screening in lead discovery: a viewpoint. Molecules 7(1):51\u201362","journal-title":"Molecules"},{"issue":"2","key":"11139_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jmgm.2010.05.008","volume":"29","author":"J Duan","year":"2010","unstructured":"Duan J, Dixon SL, Lowrie JF, Sherman W (2010) Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J Mol Graph Model 29(2):157\u2013170","journal-title":"J Mol Graph Model"},{"issue":"3","key":"11139_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1021\/acs.jcim.2c01544","volume":"63","author":"H Sharma","year":"2023","unstructured":"Sharma H, Sharma P, Urquiza U, Chastain LR, Ihnat MA (2023) Exploration of a large virtual chemical space: identification of potent inhibitors of lactate dehydrogenase-a against pancreatic cancer. J Chem Inf Model 63(3):1028\u20131043","journal-title":"J Chem Inf Model"},{"issue":"1","key":"11139_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41467-023-35829-1","volume":"14","author":"Z Yu","year":"2023","unstructured":"Yu Z, Huang J-P, Yang J, Liu C, Yan Y, Wang L et al (2023) Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors. Nat Commun 14(1):209","journal-title":"Nat Commun"},{"key":"11139_CR40","unstructured":"Astuti A, Mutiara A. 2009 Performance analysis on molecular dynamics simulation of protein using GROMACS. arXiv preprint arXiv:09120893"},{"issue":"D1","key":"11139_CR41","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al (2019) PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47(D1):D1102\u2013D1109","journal-title":"Nucleic Acids Res"},{"key":"11139_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"LZ Benet","year":"2016","unstructured":"Benet LZ, Hosey CM, Ursu O, Oprea TI (2016) BDDCS, the rule of 5 and drugability. Adv Drug Deliv Rev 101:89\u201398","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"11139_CR43","first-page":"184","volume":"8","author":"M Kowalska","year":"2018","unstructured":"Kowalska M, Fija\u0142kowski \u0141, Nowaczyk A (2018) The biological activity assessment of potential drugs acting on cardiovascular system using Lipinski and veber rules. J Educ, Health Sport 8(12):184\u2013191","journal-title":"J Educ, Health Sport"},{"key":"11139_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphar.2011.00033","volume":"2","author":"H Raunio","year":"2011","unstructured":"Raunio H (2011) In silico toxicology\u2013non-testing methods. Front Pharmacol 2:33","journal-title":"Front Pharmacol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11139-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:29:20Z","timestamp":1763728160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11139"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11139-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}